We investigated the relationship of SPIB in pan-cancer with prognosis, immune cell infiltration, tumor mutational load, and microsatellite instability and comprehensively assessed its potential as a prognostic biomarker from multiple perspectives. The gene discussed is SPIB; the disease is cancer.